Clinical Trial Update: Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for INV-102 ophthalmic solution in adults with moderate symptomatic dry eye disease has completed phases 1 and 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• INV-102 Ophthalmic Solution (INV-102)

Snippet

Sponsor: Invirsa, Inc. | Conditions: Dry Eye Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-27